A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
PHASE3
Researchers are looking for new ways to treat people with proficient mismat...
Status
Recruiting
Location
University of South Alabama, Mitchell Cancer Institute ( Site 6033)
A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)
PHASE1
This is a Phase 1/2, multicenter, randomized, open-label umbrella platform ...
Status
Recruiting
Location
University of Arizona Cancer Center-University of Arizona Cancer Center ( Site 4927)